[Psychometric properties of a German version of the Apathy Evaluation Scale].
Identifieur interne : 000650 ( PubMed/Checkpoint ); précédent : 000649; suivant : 000651[Psychometric properties of a German version of the Apathy Evaluation Scale].
Auteurs : U. Lueken [Allemagne] ; U. Seidl ; M. Schwarz ; L. Völker ; D. Naumann ; K. Mattes ; J. Schröder ; E. SchweigerSource :
- Fortschritte der Neurologie-Psychiatrie [ 0720-4299 ] ; 2006.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Alzheimer Disease (diagnosis), Alzheimer Disease (psychology), Cerebral Infarction (diagnosis), Cerebral Infarction (psychology), Female, Homes for the Aged, Humans, Male, Middle Aged, Motivation, Nursing Homes, Parkinson Disease (diagnosis), Parkinson Disease (psychology), Personality Assessment (statistics & numerical data), Personality Inventory (statistics & numerical data), Psychometrics (statistics & numerical data), Reference Values, Reproducibility of Results, Schizophrenia (diagnosis), Schizophrenic Psychology, Self Concept, Sex Factors, Social Perception, Statistics as Topic.
- MESH :
- diagnosis : Alzheimer Disease, Cerebral Infarction, Parkinson Disease, Schizophrenia.
- psychology : Alzheimer Disease, Cerebral Infarction, Parkinson Disease.
- statistics & numerical data : Personality Assessment, Personality Inventory, Psychometrics.
- Aged, Aged, 80 and over, Female, Homes for the Aged, Humans, Male, Middle Aged, Motivation, Nursing Homes, Reference Values, Reproducibility of Results, Schizophrenic Psychology, Self Concept, Sex Factors, Social Perception, Statistics as Topic.
Abstract
Apathy is a common feature of a variety of different psychiatric, neurological, and medical disorders. It can be defined as lack of motivation affecting cognitive, emotional, and overt behavioural aspects. Despite being associated with other clinical disorders, apathy can also occur as an independent syndrome (e. g., after brain injuries), now depicting a primary loss of motivation. However, apathy is predominantly assessed within the scope of superordinate psychiatric disorders. As a syndrome-independent scale, the Apathy Evaluation Scale (AES) claims to assess levels of apathy in different disorders. The aim of the present study is to provide German speaking researchers with an authorized German translation of the AES (AES (D)). The scale was evaluated in a sample of 217 subjects, consisting of patients suffering from dementia (n=120), remission-phase schizophrenia (n=20), Parkinson's disease (n=12), stroke (n=28), as well as elderly healthy controls (n=37). Preliminary results concerning the factorial structure, item characteristics, reliability, and construct validity demonstrate favourable statistical properties and suggest that the AESD is comparable to its original. The scale seems well-suited to detect apathy in different clinical groups. Differences between informant sources (clinician interview, self-, and informant ratings) seem to be related to the severity of symptoms or expert practice.
DOI: 10.1055/s-2006-932164
PubMed: 17167730
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:17167730Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Psychometric properties of a German version of the Apathy Evaluation Scale].</title><author><name sortKey="Lueken, U" sort="Lueken, U" uniqKey="Lueken U" first="U" last="Lueken">U. Lueken</name><affiliation wicri:level="1"><nlm:affiliation>Zentrum für Neuropsychologische Forschung, Universität Trier, Germany. lueken@uni-trier.de</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Zentrum für Neuropsychologische Forschung, Universität Trier</wicri:regionArea><wicri:noRegion>Universität Trier</wicri:noRegion><wicri:noRegion>Universität Trier</wicri:noRegion><wicri:noRegion>Universität Trier</wicri:noRegion></affiliation></author><author><name sortKey="Seidl, U" sort="Seidl, U" uniqKey="Seidl U" first="U" last="Seidl">U. Seidl</name></author><author><name sortKey="Schwarz, M" sort="Schwarz, M" uniqKey="Schwarz M" first="M" last="Schwarz">M. Schwarz</name></author><author><name sortKey="Volker, L" sort="Volker, L" uniqKey="Volker L" first="L" last="Völker">L. Völker</name></author><author><name sortKey="Naumann, D" sort="Naumann, D" uniqKey="Naumann D" first="D" last="Naumann">D. Naumann</name></author><author><name sortKey="Mattes, K" sort="Mattes, K" uniqKey="Mattes K" first="K" last="Mattes">K. Mattes</name></author><author><name sortKey="Schroder, J" sort="Schroder, J" uniqKey="Schroder J" first="J" last="Schröder">J. Schröder</name></author><author><name sortKey="Schweiger, E" sort="Schweiger, E" uniqKey="Schweiger E" first="E" last="Schweiger">E. Schweiger</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="RBID">pubmed:17167730</idno><idno type="pmid">17167730</idno><idno type="doi">10.1055/s-2006-932164</idno><idno type="wicri:Area/PubMed/Corpus">000664</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000664</idno><idno type="wicri:Area/PubMed/Curation">000664</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000664</idno><idno type="wicri:Area/PubMed/Checkpoint">000664</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000664</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Psychometric properties of a German version of the Apathy Evaluation Scale].</title><author><name sortKey="Lueken, U" sort="Lueken, U" uniqKey="Lueken U" first="U" last="Lueken">U. Lueken</name><affiliation wicri:level="1"><nlm:affiliation>Zentrum für Neuropsychologische Forschung, Universität Trier, Germany. lueken@uni-trier.de</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Zentrum für Neuropsychologische Forschung, Universität Trier</wicri:regionArea><wicri:noRegion>Universität Trier</wicri:noRegion><wicri:noRegion>Universität Trier</wicri:noRegion><wicri:noRegion>Universität Trier</wicri:noRegion></affiliation></author><author><name sortKey="Seidl, U" sort="Seidl, U" uniqKey="Seidl U" first="U" last="Seidl">U. Seidl</name></author><author><name sortKey="Schwarz, M" sort="Schwarz, M" uniqKey="Schwarz M" first="M" last="Schwarz">M. Schwarz</name></author><author><name sortKey="Volker, L" sort="Volker, L" uniqKey="Volker L" first="L" last="Völker">L. Völker</name></author><author><name sortKey="Naumann, D" sort="Naumann, D" uniqKey="Naumann D" first="D" last="Naumann">D. Naumann</name></author><author><name sortKey="Mattes, K" sort="Mattes, K" uniqKey="Mattes K" first="K" last="Mattes">K. Mattes</name></author><author><name sortKey="Schroder, J" sort="Schroder, J" uniqKey="Schroder J" first="J" last="Schröder">J. Schröder</name></author><author><name sortKey="Schweiger, E" sort="Schweiger, E" uniqKey="Schweiger E" first="E" last="Schweiger">E. Schweiger</name></author></analytic><series><title level="j">Fortschritte der Neurologie-Psychiatrie</title><idno type="ISSN">0720-4299</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Alzheimer Disease (diagnosis)</term><term>Alzheimer Disease (psychology)</term><term>Cerebral Infarction (diagnosis)</term><term>Cerebral Infarction (psychology)</term><term>Female</term><term>Homes for the Aged</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Motivation</term><term>Nursing Homes</term><term>Parkinson Disease (diagnosis)</term><term>Parkinson Disease (psychology)</term><term>Personality Assessment (statistics & numerical data)</term><term>Personality Inventory (statistics & numerical data)</term><term>Psychometrics (statistics & numerical data)</term><term>Reference Values</term><term>Reproducibility of Results</term><term>Schizophrenia (diagnosis)</term><term>Schizophrenic Psychology</term><term>Self Concept</term><term>Sex Factors</term><term>Social Perception</term><term>Statistics as Topic</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Alzheimer Disease</term><term>Cerebral Infarction</term><term>Parkinson Disease</term><term>Schizophrenia</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Alzheimer Disease</term><term>Cerebral Infarction</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Personality Assessment</term><term>Personality Inventory</term><term>Psychometrics</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Female</term><term>Homes for the Aged</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Motivation</term><term>Nursing Homes</term><term>Reference Values</term><term>Reproducibility of Results</term><term>Schizophrenic Psychology</term><term>Self Concept</term><term>Sex Factors</term><term>Social Perception</term><term>Statistics as Topic</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Apathy is a common feature of a variety of different psychiatric, neurological, and medical disorders. It can be defined as lack of motivation affecting cognitive, emotional, and overt behavioural aspects. Despite being associated with other clinical disorders, apathy can also occur as an independent syndrome (e. g., after brain injuries), now depicting a primary loss of motivation. However, apathy is predominantly assessed within the scope of superordinate psychiatric disorders. As a syndrome-independent scale, the Apathy Evaluation Scale (AES) claims to assess levels of apathy in different disorders. The aim of the present study is to provide German speaking researchers with an authorized German translation of the AES (AES (D)). The scale was evaluated in a sample of 217 subjects, consisting of patients suffering from dementia (n=120), remission-phase schizophrenia (n=20), Parkinson's disease (n=12), stroke (n=28), as well as elderly healthy controls (n=37). Preliminary results concerning the factorial structure, item characteristics, reliability, and construct validity demonstrate favourable statistical properties and suggest that the AESD is comparable to its original. The scale seems well-suited to detect apathy in different clinical groups. Differences between informant sources (clinician interview, self-, and informant ratings) seem to be related to the severity of symptoms or expert practice.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17167730</PMID><DateCreated><Year>2006</Year><Month>12</Month><Day>14</Day></DateCreated><DateCompleted><Year>2007</Year><Month>03</Month><Day>19</Day></DateCompleted><DateRevised><Year>2007</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0720-4299</ISSN><JournalIssue CitedMedium="Print"><Volume>74</Volume><Issue>12</Issue><PubDate><Year>2006</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Fortschritte der Neurologie-Psychiatrie</Title><ISOAbbreviation>Fortschr Neurol Psychiatr</ISOAbbreviation></Journal><ArticleTitle>[Psychometric properties of a German version of the Apathy Evaluation Scale].</ArticleTitle><Pagination><MedlinePgn>714-22</MedlinePgn></Pagination><Abstract><AbstractText>Apathy is a common feature of a variety of different psychiatric, neurological, and medical disorders. It can be defined as lack of motivation affecting cognitive, emotional, and overt behavioural aspects. Despite being associated with other clinical disorders, apathy can also occur as an independent syndrome (e. g., after brain injuries), now depicting a primary loss of motivation. However, apathy is predominantly assessed within the scope of superordinate psychiatric disorders. As a syndrome-independent scale, the Apathy Evaluation Scale (AES) claims to assess levels of apathy in different disorders. The aim of the present study is to provide German speaking researchers with an authorized German translation of the AES (AES (D)). The scale was evaluated in a sample of 217 subjects, consisting of patients suffering from dementia (n=120), remission-phase schizophrenia (n=20), Parkinson's disease (n=12), stroke (n=28), as well as elderly healthy controls (n=37). Preliminary results concerning the factorial structure, item characteristics, reliability, and construct validity demonstrate favourable statistical properties and suggest that the AESD is comparable to its original. The scale seems well-suited to detect apathy in different clinical groups. Differences between informant sources (clinician interview, self-, and informant ratings) seem to be related to the severity of symptoms or expert practice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lueken</LastName><ForeName>U</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Zentrum für Neuropsychologische Forschung, Universität Trier, Germany. lueken@uni-trier.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seidl</LastName><ForeName>U</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Schwarz</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Völker</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Naumann</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Mattes</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Schröder</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Schweiger</LastName><ForeName>E</ForeName><Initials>E</Initials></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Die Apathy Evaluation Scale: Erste Ergebnisse zu den psychometrischen Eigenschaften einer deutschsprachigen Ubersetzung der Skala.</VernacularTitle></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Fortschr Neurol Psychiatr</MedlineTA><NlmUniqueID>8103137</NlmUniqueID><ISSNLinking>0720-4299</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002544" MajorTopicYN="N">Cerebral Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006707" MajorTopicYN="N">Homes for the Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009042" MajorTopicYN="Y">Motivation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009735" MajorTopicYN="N">Nursing Homes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010552" MajorTopicYN="N">Personality Assessment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010555" MajorTopicYN="N">Personality Inventory</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011594" MajorTopicYN="N">Psychometrics</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012559" MajorTopicYN="N">Schizophrenia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012565" MajorTopicYN="Y">Schizophrenic Psychology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012649" MajorTopicYN="N">Self Concept</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012938" MajorTopicYN="N">Social Perception</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013223" MajorTopicYN="N">Statistics as Topic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>12</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>3</Month><Day>21</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>12</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17167730</ArticleId><ArticleId IdType="doi">10.1055/s-2006-932164</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li></country></list><tree><noCountry><name sortKey="Mattes, K" sort="Mattes, K" uniqKey="Mattes K" first="K" last="Mattes">K. Mattes</name><name sortKey="Naumann, D" sort="Naumann, D" uniqKey="Naumann D" first="D" last="Naumann">D. Naumann</name><name sortKey="Schroder, J" sort="Schroder, J" uniqKey="Schroder J" first="J" last="Schröder">J. Schröder</name><name sortKey="Schwarz, M" sort="Schwarz, M" uniqKey="Schwarz M" first="M" last="Schwarz">M. Schwarz</name><name sortKey="Schweiger, E" sort="Schweiger, E" uniqKey="Schweiger E" first="E" last="Schweiger">E. Schweiger</name><name sortKey="Seidl, U" sort="Seidl, U" uniqKey="Seidl U" first="U" last="Seidl">U. Seidl</name><name sortKey="Volker, L" sort="Volker, L" uniqKey="Volker L" first="L" last="Völker">L. Völker</name></noCountry><country name="Allemagne"><noRegion><name sortKey="Lueken, U" sort="Lueken, U" uniqKey="Lueken U" first="U" last="Lueken">U. Lueken</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Rhénanie/explor/UnivTrevesV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000650 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000650 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Rhénanie
|area= UnivTrevesV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:17167730
|texte= [Psychometric properties of a German version of the Apathy Evaluation Scale].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:17167730" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a UnivTrevesV1
| This area was generated with Dilib version V0.6.31. |  |